Logo

American Heart Association

  15
  0


Final ID: MP1264

Chronic kidney disease in US adults with uncontrolled hypertension: prevalence, characteristics, and mortality, an NHANES analysis

Abstract Body (Do not enter title and authors here): Introduction
The prevalence of uncontrolled hypertension (HTN) remains high in the United States (US), despite the availability of multiple oral antihypertensive medications. Given the bidirectional relationship between high blood pressure (BP) and chronic kidney disease (CKD), future research and care models would benefit from understanding the characteristics and mortality of adults with both uncontrolled HTN and CKD.
Research Questions
This study aimed to estimate the prevalence of CKD among US adults with uncontrolled HTN and to compare the sociodemographic characteristics, clinical characteristics, and mortality between those with and without CKD.
Methods
We utilized data from the US National Health and Nutrition Examination Survey (NHANES) 2013-2018 (baseline) and linked it to the National Death Index as of December 31, 2019 (follow-up). Adults with uncontrolled HTN, defined as average BP ≥130/80 mm Hg with a prescription of ≥1 antihypertensive medication, at baseline were included. CKD was defined using estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2 at baseline. We used logistic regression models to compare characteristics at baseline and Cox proportional hazards models to compare mortality at follow-up between those with and without CKD.
Results
Among 2,813 adults (weighted: 33 million) with uncontrolled HTN, the prevalence of CKD was 15.6%. Independent of age and sex, adults with CKD were more likely to have BP ≥140/90 mm Hg (adjusted odds ratio 1.5 [95% confidence interval: 1.2-2.0]), prescribed ≥3 antihypertensive medications (1.5 [1.2-2.0]), have higher prevalence of any cardiovascular disease (CVD, 1.5 [1.1-1.9]), heart failure (2.2 [1.6-3.0]), and diabetes (1.4 [1.1-1.8]) than those without CKD. They were also more likely to have ≥1 hospitalization (1.6 [1.2-2.2]) and ≥6 healthcare visits (1.6 [1.2-2.1]) in the past year, compared to those without CKD. Furthermore, independent of age and sex, the risk of all-cause, CVD-related, and heart disease-related mortality at follow-up was 2.2 (1.6-2.9), 4.5, (2.3-8.5), and 5.6 (2.3-13.8) times higher in adults with CKD than in those without CKD, respectively.
Conclusions
Our study results highlight that nearly 1 in 6 US adults with uncontrolled HTN were affected by CKD. In addition, CKD was associated with a greater mortality risk. Future investigations and better care models are needed to manage adults with both uncontrolled HTN and CKD.
  • Liu, Xinyue  ( Regeneron , White Plains , New York , United States )
  • Meadows, Judy  ( Regeneron , White Plains , New York , United States )
  • Mehta, Isha  ( Regeneron , White Plains , New York , United States )
  • Thakur, Mazhar  ( Regeneron , White Plains , New York , United States )
  • Knox, Caitlin  ( Regeneron , White Plains , New York , United States )
  • Author Disclosures:
    Xinyue Liu: DO have relevant financial relationships ; Employee:Regeneron:Active (exists now) | Judy Meadows: No Answer | Isha Mehta: DO have relevant financial relationships ; Employee:Regeneron Pharmaceuticals:Active (exists now) | Mazhar Thakur: No Answer | Caitlin Knox: DO have relevant financial relationships ; Employee:Regeneron Pharmaceuticals:Active (exists now) ; Individual Stocks/Stock Options:Vertex Pharmaceuticals:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

The Interplay of Demographic and Social Factors with Hypertension in Mediating Target Organ Disease

Sunday, 11/09/2025 , 11:50AM - 12:45PM

Moderated Digital Poster Session

More abstracts on this topic:

A Longitudinal 20-year Analysis Indicates Acceleration of Cardiometabolic Comorbidities on Dementia Risk

Lihua Huang, Danish Muhammad, Auyeung Tw, Jenny Lee, Kwok Timothy, Abrigo Jill, Wei Yingying, Lo Cecilia, Fung Erik

A20 in the Kidney Epithelium Attenuates Angiotensin II-induced Hypertension by Constraining Renal Tubular NHE3 Expression

Lu Xiaohan, Ren Jiafa, Wen Yi, Griffiths Robert, Yang Ting, Hammer Gianna, Zhuo Jia, Crowley Steven

More abstracts from these authors:
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal Antibody

Ahmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor

You have to be authorized to contact abstract author. Please, Login
Not Available